Core Laboratories (CLB) Income from Continuing Operations (2022 - 2026)

Core Laboratories' Income from Continuing Operations history runs 5 years deep, the most recent figure standing at 753000.0 for Q1 2026.

• On a quarterly basis, Income from Continuing Operations fell 1191.3% year-over-year to 753000.0 in Q1 2026; TTM through Mar 2026 was 29523000.0, a 11.25% decrease from a year earlier, with the FY2025 full-year figure at 30391000.0, down 17.04% from the prior year.
• Income from Continuing Operations declined to 753000.0 in Q1 2026 per CLB's latest filing, from 5129000.0 in the prior quarter.
• Across five years, Income from Continuing Operations topped out at 22929000.0 in Q2 2023 and bottomed at 8584000.0 in Q4 2023.
• The 5-year median for Income from Continuing Operations is 8425000.0 (2022), against an average of 7289562.5.
• Across the five-year window, Income from Continuing Operations jumped 239.7% in 2024 and slumped 1191.3% in 2026, its largest moves.
• Year by year, Income from Continuing Operations stood at 9569000.0 in 2022, then sank by 189.71% to 8584000.0 in 2023, then soared by 239.7% to 11992000.0 in 2024, then sank by 57.23% to 5129000.0 in 2025, then plunged by 114.68% to 753000.0 in 2026.
• Per Business Quant, the three latest CLB Income from Continuing Operations figures stand at 753000.0 (Q1 2026), 5129000.0 (Q4 2025), and 14478000.0 (Q3 2025).